Retour aux appels d'offres

Médicaments antithrombotiques, médicaments hémostatiques, médicaments agissant sur le système cardiovasculaire, tous les autres agents thérapeutiques, autres agents hématologiques

Ouvert
Date limite
21 jours restants
Mars 23, 2026
Détails du contrat
Catégorie
Fournitures
Référence
304124
Valeur
€2,800,000
Lieu
Estonia, Estonie
Publié
Février 18, 2026
Code CPV
Critères d'évaluation
Total cost of drug with active ingredient sodium heparin100%
Total cost of drug with active ingredient sodium enoxaparin100%
Total cost of drug with active ingredient tirofiban100%
Total cost of drug with active ingredient alteplase100%
Total cost of drug with active ingredient tenecteplase100%
Total cost of drug with active ingredient rivaroxaban100%
Total cost of drug with active ingredient apixaban100%
Total cost of drug with active ingredient edoxaban100%
Total cost of drug with active ingredient fondaparinux sodium100%
Total cost of drug with active ingredient tranexamic acid100%
Total cost of drug with active ingredient levosimendan100%
Total cost of drug with active ingredient adenosine100%
Calendrier du projet

Publication de l'appel d'offres

Février 18, 2026

Date limite pour les questions

Mars 16, 2026

Date limite de soumission

Mars 23, 2026

Ouverture de l'appel d'offres

Mars 23, 2026

Probabilité de gainPRO
🔒
Passer au Professionnel
Consultez votre probabilité de gain estimée basée sur les données historiques.
Passer au Professionnel →
Intelligence acheteurPRO
🔒
Débloquer l'intelligence acheteur
Consultez les modèles de dépenses, les procédures préférées et plus encore.
Passer au Professionnel →
Aperçu du secteurPRO
🔒
Débloquer les aperçus du secteur
Consultez les prix gagnants moyens, les niveaux de concurrence et les tendances du marché.
Passer au Professionnel →
Voir l'original
Budget
€2,800,000
Durée
Non spécifié
Lieu
Estonia
Type
Fournitures
80
Score de qualité/100
Excellent
Référentiel de marché
Prix moyen gagnant
€92,792
Offres moyennes
2.2
Concurrence
Faible
PME gagnantes
86%
3,220 appels d'offres analysés

Description originale de l'appel d'offres

Pour l'achat de médicaments antithrombotiques, de médicaments hémostatiques, de médicaments agissant sur le système cardiovasculaire, de tous les autres agents thérapeutiques, d'autres agents hématologiques
Soumission électronique

Analyse des risques

Veuillez vous connecter pour utiliser l'analyse des risques.

Se connecter

Stratégie gagnante

Connectez-vous pour accéder aux recommandations de stratégie gagnante.

Se connecter

Concurrents

Passez à un plan supérieur pour voir quelles entreprises sont susceptibles de soumissionner pour cet appel d'offres, basé sur les données historiques.

Se connecter

Exigences et qualifications

9 exigences dans 5 catégories

Soumission (4)
Obligatoire (1)
Conformité (1)
Technique (2)
Financier (1)
SUBMISSION REQUIREMENTS4
--Submit a completed application form confirming review of tender documents, agreement to conditions, and validity of the offer.
--Submit a completed table with the technical proposal including unit prices and total costs for active ingredients, dosage forms, and quantities.
--If joint bidders, submit a power of attorney.
MANDATORY EXCLUSION GROUNDS1
--Do not involve subcontractors or suppliers linked to the Russian Federation by more than 10%.
ELIGIBILITY REQUIREMENTS1
--Agree to the terms and conditions of the draft framework agreement.
TECHNICAL CAPABILITY REQUIREMENTS2
--Offer medicines meeting technical specifications (active ingredients, dosage forms, quantities).
--Ability to offer equivalent products that meet the criteria.
FINANCIAL REQUIREMENTS1
--The bid price must include the total cost for each drug component (sodium heparin, enoxaparin, tirofiban) excluding taxes.

Aperçu des exigences

Inscrivez-vous pour consulter les exigences et l'analyse complètes

Documents

7 documents disponibles avec des résumés IA

VastavustingimusedPDF
304124_vastavustingimused.pdf -- 305.6 KB

This document outlines the tender submission conditions, including the requirement not to involve subcontractors or suppliers linked to the Russian Federation beyond 10%, the procedure for submitting a power of attorney for joint bidders, and rules for marking business secrets.

Pakkuja esitab täidetud hankemenetluses osalemise avalduseDOC
304124 Hankemenetluses osalemise avaldus.docx -- 50.8 KB

Bidders must submit a completed application confirming their review of tender documents, agreement to terms, and the validity of their offer.

Pakkuja esitab täidetud tabeli "304124 Tehniline ettepanek ühikuhinnad"XLS
304124 Tehniline ettepanek ühikuhinnad.xlsx -- 37.5 KB

Bidders must submit a completed table detailing their technical proposal for unit prices and total costs of medicines, including active substances, drug forms, and quantities.

Hindamiskriteeriumid ja hinnatavad näitajadPDF
304124_hindamiskriteeriumid.pdf -- 88.1 KB

This document outlines the evaluation criteria for the tender, specifying that bids will be assessed solely on the total cost of each drug part (sodium heparin, enoxaparin, tirofiban) without taxes, with the lowest price receiving maximum points.

Hankepass täiendatavate selgitustegaPDF
304124_hankepass_taiendavate_selgitustega.pdf -- 75.6 KB

This ESPD document is an explanatory guide outlining the contracting authority's conditions and expected qualification requirements for bidders, but it is not to be submitted as a filled form.

Lepingu projektDOC
304124 Apteegikauba riigihanke raamleping.doc... -- 55.2 KB

This is a draft framework agreement for the public procurement of pharmaceutical goods, detailing the terms and conditions for the supply of medicines to buyers, including SA Põhja-Eesti Regionaalhaigla.

Tehniline kirjeldusXLS
304124 Tehniline kirjeldus.xlsx -- 27.7 KB

This document specifies the technical requirements for the medicines to be procured, listing specific active substances, pharmaceutical forms, and quantities that the contracting authority intends to purchase, emphasizing the acceptance of equivalents.

Aperçu des documents

Inscrivez-vous pour consulter les résumés et l'analyse des documents

80
Excellent

Score de qualité de l'appel d'offres

This public procurement is well-structured and transparent, particularly regarding evaluation criteria, but it has shortcomings in contract duration and sustainability aspects. The tender demonstrates good compliance with legal frameworks and promotes fair competition.

Répartition du score

Conformité légale85/100

The tender generally complies with legal requirements, including the presence of an ESPD and specific exclusion grounds related to the Russian Federation, indicating adherence to current geopolitical regulations. The procedure type and CPV codes are clearly defined.

Clarté90/100

The tender's description, requirements, and evaluation criteria are exceptionally clear and unambiguous. The technical specifications accept equivalents, and the evaluation is solely based on the lowest price, ensuring transparency.

Exhaustivité75/100

Basic information, financial details, and key deadlines are provided. However, the explicit contract duration beyond the tender validity and a specific NUTS code or delivery location are not clearly stated, which are notable omissions for a procurement of physical goods.

•Missing explicit contract duration beyond tender validity.
•Missing specific delivery/service location (NUTS code empty).
Équité95/100

The tender exhibits high fairness due to objective, lowest-price-based evaluation criteria and the explicit acceptance of equivalent products in technical specifications. Electronic submission ensures equal access, and the value is fully disclosed.

Aspect pratique70/100

Electronic submission and e-procurement are supported, enhancing practicality. However, the absence of a clear contract start date and the precise contract duration (beyond tender validity) could pose minor planning challenges for potential bidders.

•Missing explicit contract start date.
•Missing explicit contract duration.
Cohérence des données85/100

The data provided is largely consistent and logical, with dates aligning correctly. Minor inconsistencies include the empty NUTS code field and the lack of explicit contract duration, but these do not indicate major data integrity issues.

•NUTS code field is empty.
•Contract duration is not explicitly stated.
Durabilité40/100

The tender does not explicitly incorporate green, social, or innovation procurement criteria. While the exclusion ground related to the Russian Federation has ethical implications, it does not align with typical sustainability metrics in procurement.

•No explicit green procurement criteria.
•No explicit social criteria.

Points forts

Clear and objective evaluation criteria (lowest price).
Comprehensive documentation with acceptance of equivalent products.
Electronic submission and e-procurement enabled.
Transparency in estimated value and tender details.
Compliance with geopolitical exclusion grounds (Russian Federation links).

Préoccupations

Missing explicit contract duration beyond tender validity.
Lack of specific delivery/service location (NUTS code empty).
Absence of explicit green, social, or innovation procurement criteria.
Contract start date not explicitly stated.

Recommandations

1. Specify the expected contract duration and start date within the tender documents.
2. Include the NUTS code and clarify delivery locations for the medicines.
3. Consider integrating sustainability criteria (e.g., packaging, supply chain ethics) in future tenders, where applicable.

Aperçu de la notation IA

Inscrivez-vous pour consulter les exigences et l'analyse complètes

Analyse complète du score de qualité
Répartition détaillée des sous-scores
Aperçu des forces et des préoccupations
Recommandations stratégiques

Aucune carte de crédit requise • Configuration en 2 minutes

Ajouter au Pipeline